These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 16415133)

  • 21. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts.
    Rössle M; Siegerstetter V; Olschewski M; Ochs A; Berger E; Haag K
    Am J Gastroenterol; 2001 Dec; 96(12):3379-83. PubMed ID: 11774952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.
    Rössle M; Siegerstetter V; Euringer W; Olschewski M; Kromeier J; Kurz K; Langer M
    Acta Radiol; 2006 Sep; 47(7):660-6. PubMed ID: 16950701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].
    Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ
    Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures.
    Montgomery A; Ferral H; Vasan R; Postoak DW
    Cardiovasc Intervent Radiol; 2005; 28(3):307-12. PubMed ID: 15886944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome.
    Darwish Murad S; Luong TK; Pattynama PM; Hansen BE; van Buuren HR; Janssen HL
    Liver Int; 2008 Feb; 28(2):249-56. PubMed ID: 18251982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting.
    Wallace MJ; Madoff DC; Ahrar K; Warneke CL
    Cancer; 2004 Jul; 101(2):337-45. PubMed ID: 15241832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
    Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
    Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
    Maleux G; Heye S; Verslype C; Nevens F
    J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and chronic complications after implantation of a transjugular intrahepatic portosystemic shunt--a prospective study in 53 patients.
    Gschwantler M; Gebauer A; Vavrik J; Madani B; Rohrmoser M; Schrutka-Kölbl C; Brownstone E; Fleischer J; Tscholakoff D; Weiss W
    Z Gastroenterol; 1997 Nov; 35(11):999-1005. PubMed ID: 9429285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful recanalization of portal vein thrombosis before liver transplantation using transjugular intrahepatic portosystemic shunt.
    Liatsos C; Vlachogiannakos J; Patch D; Tibballs J; Watkinson A; Davidson B; Rolles K; Burroughs AK
    Liver Transpl; 2001 May; 7(5):453-60. PubMed ID: 11349268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravascular ultrasound-guided direct intrahepatic portacaval shunt: description of technique and technical refinements.
    Petersen B
    J Vasc Interv Radiol; 2003 Jan; 14(1):21-32. PubMed ID: 12525583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report.
    Wróblewski T; Rowiński O; Ziarkiewicz-Wróblewska B; Górnicka B; Albrecht J; Jones EA; Krawczyk M
    Transplant Proc; 2006; 38(1):204-8. PubMed ID: 16504703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years' experience from a single tertiary medical center.
    Pan JJ; Chen C; Caridi JG; Geller B; Firpi R; Machicao VI; Hawkins IF; Soldevila-Pico C; Nelson DR; Morelli G
    J Vasc Interv Radiol; 2008 Nov; 19(11):1576-81. PubMed ID: 18789725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The transjugular intrahepatic portosystemic stent-shunt (TIPS) as rescue therapy for complete Budd-Chiari syndrome and portal vein thrombosis.
    Opitz T; Buchwald AB; Lorf T; Awuah D; Ramadori G; Nolte W
    Z Gastroenterol; 2003 May; 41(5):413-8. PubMed ID: 12772054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation.
    Wils A; van der Linden E; van Hoek B; Pattynama PM
    J Clin Gastroenterol; 2009; 43(10):982-4. PubMed ID: 19417681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved patency of transjugular intrahepatic portosystemic shunts in humans: creation and revision with PTFE stent-grafts.
    Haskal ZJ
    Radiology; 1999 Dec; 213(3):759-66. PubMed ID: 10580950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Portosystemic shunt via the left branch of portal vein for the prevention of encephalopathy following transjugular intrahepatic portosystemic shunt].
    Chu J; Sun X; Piao L; Chen Z; Huang H; Lu C; Xu J
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):437-40. PubMed ID: 12502447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt.
    Khuroo MS; Al-Suhabani H; Al-Sebayel M; Al Ashgar H; Dahab S; Khan MQ; Khalaf HA
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1494-502. PubMed ID: 16174064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison study of Doppler ultrasound surveillance of expanded polytetrafluoroethylene-covered stent versus bare stent in transjugular intrahepatic portosystemic shunt.
    Huang Q; Wu X; Fan X; Cao J; Han J; Xu L; Li N
    J Clin Ultrasound; 2010 Sep; 38(7):353-60. PubMed ID: 20533444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.